Loading...
294 China Disease Specific Drugs Reports
Country Covered: China
Study Period: 2019 - 2030
Major Players: Eli Lilly and Company, Boehringer Ingelheim, AstraZeneca, Sanofi, Novo Nordisk
Country Covered: China
Study Period: 2019 - 2030
Major Players: Merck, Bayer, Amgen, AstraZeneca, Johnson & Johnson
Country Covered: China
Study Period: 2019 - 2030
Major Players: Abbvie, Pfizer, Teva Pharmaceutical Industries, Sun Pharmaceuticals Industries, Novartis
Country Covered: China
Study Period: 2019 - 2030
Major Players: AstraZeneca, Boehringer Ingelheim, Novo Nordisk, Eli Lilly and Company, Sanofi
Country Covered: China
Study Period: 2019 - 2030
Major Players: Stryker, Zimmer Biomet, Conmed, Arthrex, Medtronic
Country Covered: China
Study Period: 2019 - 2030
Major Players: Sanofi, Novo Nordisk, Takeda Pharmaceuticals, Astellas Pharma, AstraZeneca
Country Covered: China
Study Period: 2021 - 2030
Major Players: Abbvie, Bristol-Myers Squibb, Roche, Gilead Sciences, Merck
Country Covered: China
Study Period: 2019 - 2030
Major Players: 3M, ACell, BSN Medical, Cardinal Health, Convatec
Country Covered: China
Study Period: 2019 - 2030
Major Players: 3M, Beckton Dickinson, bioMérieux, Sterigenics International, Johnson & Johnson
Country Covered: China
Study Period: 2019 - 2030
Major Players: 3M, Blistex, Colgate-Palmolive Company, Church & Dwight, GlaxoSmithKline
Country Covered: China
Study Period: 2019 - 2030
Major Players: Smiths Group, Johnson & Johnson, Molnlycke Health Care, 3M, Cardinal Health
Country Covered: China
Study Period: 2021 - 2030
Major Players: DJO Global, Teikoku Pharma, Zimmer Biomet, 3M, AKSIGEN
Country Covered: China
Study Period: 2021 - 2030
Major Players: Koninklijke Philips, Colgate-Palmolive Company, DMG Dental, VOCO, Dentsply Sirona
Country Covered: China
Study Period: 2019 - 2030
Major Players: Alcon, Bausch Health, Johnson & Johnson, Carl Zeiss, Topcon
Country Covered: China
Study Period: 2024 - 2030
Major Players: Johnson & Johnson, Sanofi, GlaxoSmithKline, Roche, Leti Pharma
Country Covered: China
Study Period: 2019 - 2030
Major Players: Abbvie, Roche, GlaxoSmithKline, Lupin, Pfizer
Country Covered: China
Study Period: 2021 - 2030
Major Players: DermaMed Solutions, Abbvie, Obagi Cosmeceuticals, Merz Pharma, L'Oréal SA
Country Covered: China
Study Period: 2019 - 2030
Major Players: Teva Pharmaceutical Industries, Johnson & Johnson, Pfizer, Merck, Abbvie
Country Covered: China
Study Period: 2021 - 2030
Major Players: Johnson & Johnson, Novartis, Bausch Health, Santen Pharmaceuticals, Abbvie
Country Covered: China
Study Period: 2019 - 2030
Major Players: Medtronic, Astellas Pharma, Macleods Pharmaceuticals, Pfizer, AbbVie Ltd.
Country Covered: China
Study Period: 2019 - 2030
Major Players: Abbvie, Merck, Novartis, Bausch Health, Johnson & Johnson
Country Covered: China
Study Period: 2019 - 2030
Major Players: Takeda Pharmaceuticals, Bristol-Myers Squibb, Lupin, Accord Healthcare, Otsuka
Country Covered: China
Study Period: 2019 - 2030
Major Players: Abbvie, Gilead Sciences, Mylan, Alaxia, Vertex Pharmaceuticals
Country Covered: China
Study Period: 2019 - 2030
Major Players: Novartis, Abbvie, Aciont, Amgen, Tarsier Pharma
Country Covered: China
Study Period: 2019 - 2030
Major Players: Abbvie, Abbvie, AstraZeneca, GlaxoSmithKline, Janssen
Country Covered: China
Study Period: 2019 - 2030
Major Players: Boehringer Ingelheim, UCB, Novartis, Teva Pharmaceutical Industries, Merck
Country Covered: China
Study Period: 2019 - 2030
Major Players: Abbvie, Gilead Sciences, GlaxoSmithKline, Roche, Merck
Country Covered: China
Study Period: 2019 - 2030
Major Players: Abbvie, Eli Lilly and Company, Teva Pharmaceutical Industries, Pfizer, GlaxoSmithKline
Country Covered: China
Study Period: 2019 - 2030
Major Players: Ipsen, Merz Pharma, Teva Pharmaceutical Industries, Supernus Pharmaceuticals, Abbvie
Country Covered: China
Study Period: 2019 - 2030
Major Players: Abbvie, Merck, Teva Pharmaceutical Industries, Viatris, Roche